We are live on ! Find out more
PA

Perceptive Advisors Portfolio holdings

AUM $5.12B
1-Year Est. Return 314.02%
This Fund
S&P 500
This Quarter Est. Return
-14.51%
1 Year Est. Return
+314.02%
3 Year Est. Return
+1,498.66%
5 Year Est. Return
+2,457.67%
10 Year Est. Return
+48,821.41%
AUM
$1.25B
AUM Growth
-$409M
Cap. Flow
-$35.9M
Cap. Flow %
-2.87%
Top 10 Hldgs %
50.14%
Holding
212
New
40
Increased
31
Reduced
43
Closed
54

Top Buys

Rank Stock Value
1
GBT
Global Blood Therapeutics, Inc.
GBT
+$43.5M
2
RGNX icon
Regenxbio
RGNX
+$19.9M
3
ARAV
Aravive, Inc. Common Stock
ARAV
+$15.6M
4
ZYNE
Zynerba Pharmaceuticals, Inc
ZYNE
+$14.2M
5
LJPC
La Jolla Pharmaceutical Company
LJPC
+$12.7M

Top Sells

Rank Stock Value
1
ZSPH
ZS PHARMA INC COMS TK (DE)
ZSPH
+$19M
2
AGN
Allergan plc
AGN
+$18M
3
ANIP icon
ANI Pharmaceuticals
ANIP
+$17.5M
4
CBPO
China Biologic Products Holdings, Inc.
CBPO
+$17M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$16.5M

Sector Composition

Rank Sector Weight
1 Healthcare 77.95%
2 Consumer Discretionary 0.07%
3 Financials 0.04%
4 Energy 0.02%
5 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PCRX icon
176
Pacira BioSciences
PCRX
$1.04B
– –
-50
Closed -$4K
RGLS
177
PUT
DELISTED
Regulus Therapeutics
RGLS
– –
-1,667
Closed -$2.2M
SGMO
178
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
– –
-800,000
Closed -$8.87M
SSO icon
179
ProShares Ultra S&P500
SSO
$7.52B
– –
-240,000
Closed -$1.87M
SUPN icon
180
Supernus Pharmaceuticals
SUPN
$2.7B
– –
-19,470
Closed -$331K
THC icon
181
Tenet Healthcare
THC
$22.2B
– –
-8,500
Closed -$492K
TVTX icon
182
PUT
Travere Therapeutics
TVTX
$5.17B
– –
-100,000
Closed -$3.31M
UHS icon
183
Universal Health Services
UHS
$10.2B
– –
-1,883
Closed -$268K
UNH icon
184
UnitedHealth
UNH
$382B
– –
-1,685
Closed -$206K
VTRS icon
185
Viatris
VTRS
$20.8B
– –
-215,133
Closed -$14.6M
ZBH icon
186
Zimmer Biomet
ZBH
$18.8B
– –
-139,249
Closed -$14.8M
TCON
187
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
– –
-500
Closed -$1.29M
ABMD
188
DELISTED
Abiomed Inc
ABMD
– –
-10,000
Closed -$657K
RDUS
189
DELISTED
Radius Health, Inc.
RDUS
– –
-235,530
Closed -$15.9M
EPZM
190
DELISTED
Epizyme, Inc
EPZM
– –
-60,000
Closed -$1.44M
XENT
191
DELISTED
Intersect ENT, Inc
XENT
– –
-10,251
Closed -$293K
EVFM
192
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
– –
-222
Closed -$180K
IMMU
193
DELISTED
Immunomedics Inc
IMMU
– –
-600,000
Closed -$2.44M
IMMU
194
PUT
DELISTED
Immunomedics Inc
IMMU
– –
-700,000
Closed -$2.84M
TTPH
195
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
– –
-5,000
Closed -$4.74M
PTLA
196
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
– –
-111,103
Closed -$5.06M
AGN
197
DELISTED
Allergan plc
AGN
– –
-59,185
Closed -$18M
GNMX
198
DELISTED
Aevi Genomic Medicine Inc
GNMX
– –
-465,225
Closed -$2.85M
KERX
199
DELISTED
Keryx Biopharmaceuticals Inc
KERX
– –
-34,380
Closed -$343K
CBPO
200
DELISTED
China Biologic Products Holdings, Inc.
CBPO
– –
-147,604
Closed -$17M
5 6 7
8
9

Similar funds

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
TAM
Todd Asset Management Louisville, Kentucky $5.11B AUM 34.73% 1-Year Est. Return
CIA
Choate Investment Advisors Boston, Massachusetts $5.11B AUM 17.2% 1-Year Est. Return
AC
AKO Capital London, United Kingdom $5.11B AUM 2.56% 1-Year Est. Return
EIC
Equity Investment Corp Atlanta, Georgia $5.11B AUM 8.63% 1-Year Est. Return
CIC
Carnegie Investment Counsel Pepper Pike, Ohio $5.13B AUM 22.98% 1-Year Est. Return
CS
Cannell & Spears New York $5.1B AUM 31.77% 1-Year Est. Return
NC
Nicholas Company Milwaukee, Wisconsin $5.1B AUM 8.43% 1-Year Est. Return

Perceptive Advisors's Q3 2015 Portfolio in Review

As of Q3 2015, Perceptive Advisors held 212 positions worth $1.25B, down 25% from $1.66B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Perceptive Advisors's Q3 2015 filing shows 40 new, 31 increased, 43 reduced and 54 closed positions. Its largest new stake was Global Blood Therapeutics, Inc.: 921,800 shares worth $38.9M. The largest sale was ZS PHARMA INC COMS TK (DE), an estimated $19M.

By sector, the portfolio is most concentrated in Healthcare at 78% of assets, up from 77% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Perceptive Advisors's largest Q3 2015 buy was Global Blood Therapeutics, Inc.: 921,800 shares worth $38.9M.
  • Perceptive Advisors added most to Aravive, Inc. Common Stock in Q3 2015, an estimated $15.6M increase.
  • Perceptive Advisors's biggest Q3 2015 reduction was ANI Pharmaceuticals, cutting an estimated $17.5M.
  • Perceptive Advisors fully exited ZS PHARMA INC COMS TK (DE) in Q3 2015, selling an estimated $19M.
  • Perceptive Advisors's ten largest holdings make up 50% of its $1.25B portfolio in Q3 2015.
  • Perceptive Advisors opened 40 new positions and closed 54 in Q3 2015.
  • Perceptive Advisors's portfolio value fell 25% quarter-over-quarter to $1.25B.

Based on Perceptive Advisors's 13F filing for Q3 2015, filed 16 Nov 2015.